{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,20]],"date-time":"2026-04-20T02:48:50Z","timestamp":1776653330319,"version":"3.51.2"},"reference-count":178,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,7,17]],"date-time":"2025-07-17T00:00:00Z","timestamp":1752710400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,7,17]],"date-time":"2025-07-17T00:00:00Z","timestamp":1752710400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/100012352","name":"Universit\u00e0 degli Studi di Milano","doi-asserted-by":"publisher","award":["piano di sviluppo della ricerca (PSR) UNIMI \u2014linea B"],"award-info":[{"award-number":["piano di sviluppo della ricerca (PSR) UNIMI \u2014linea B"]}],"id":[{"id":"10.13039\/100012352","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100012352","name":"Universit\u00e0 degli Studi di Milano","doi-asserted-by":"publisher","award":["piano di sviluppo della ricerca (PSR) UNIMI \u2014linea B"],"award-info":[{"award-number":["piano di sviluppo della ricerca (PSR) UNIMI \u2014linea B"]}],"id":[{"id":"10.13039\/100012352","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100012352","name":"Universit\u00e0 degli Studi di Milano","doi-asserted-by":"publisher","award":["piano di sviluppo della ricerca (PSR) UNIMI \u2014linea B"],"award-info":[{"award-number":["piano di sviluppo della ricerca (PSR) UNIMI \u2014linea B"]}],"id":[{"id":"10.13039\/100012352","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100003914","name":"Kennedy's Disease Association","doi-asserted-by":"publisher","award":["2018 grant"],"award-info":[{"award-number":["2018 grant"]}],"id":[{"id":"10.13039\/100003914","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100003914","name":"Kennedy's Disease Association","doi-asserted-by":"publisher","award":["2020 grant"],"award-info":[{"award-number":["2020 grant"]}],"id":[{"id":"10.13039\/100003914","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002803","name":"Fondazione Cariplo","doi-asserted-by":"publisher","award":["2021-1544"],"award-info":[{"award-number":["2021-1544"]}],"id":[{"id":"10.13039\/501100002803","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100021856","name":"Ministero dell'Universit\u00e0 e della Ricerca","doi-asserted-by":"publisher","award":["PRIN PNRR P2022B5J32"],"award-info":[{"award-number":["PRIN PNRR P2022B5J32"]}],"id":[{"id":"10.13039\/501100021856","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100021856","name":"Ministero dell'Universit\u00e0 e della Ricerca","doi-asserted-by":"publisher","award":["PRIN n. 2020PBS5MJ"],"award-info":[{"award-number":["PRIN n. 2020PBS5MJ"]}],"id":[{"id":"10.13039\/501100021856","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100021856","name":"Ministero dell'Universit\u00e0 e della Ricerca","doi-asserted-by":"publisher","award":["PRIN n. 2022EFLFL8"],"award-info":[{"award-number":["PRIN n. 2022EFLFL8"]}],"id":[{"id":"10.13039\/501100021856","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000069","name":"National Institute of Arthritis and Musculoskeletal and Skin Diseases","doi-asserted-by":"publisher","award":["R21AR080407"],"award-info":[{"award-number":["R21AR080407"]}],"id":[{"id":"10.13039\/100000069","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000069","name":"National Institute of Arthritis and Musculoskeletal and Skin Diseases","doi-asserted-by":"publisher","award":["R21AR080407"],"award-info":[{"award-number":["R21AR080407"]}],"id":[{"id":"10.13039\/100000069","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002426","name":"Fondazione Telethon","doi-asserted-by":"publisher","award":["GGP19128"],"award-info":[{"award-number":["GGP19128"]}],"id":[{"id":"10.13039\/501100002426","id-type":"DOI","asserted-by":"publisher"}]},{"name":"AFM Telethon, France","award":["23236"],"award-info":[{"award-number":["23236"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cell Commun Signal"],"DOI":"10.1186\/s12964-025-02351-4","type":"journal-article","created":{"date-parts":[[2025,7,17]],"date-time":"2025-07-17T17:28:15Z","timestamp":1752773295000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Targeting androgen receptor stability and degradation: approaches for developing a therapy for spinal and bulbar muscular atrophy"],"prefix":"10.1186","volume":"23","author":[{"given":"Riccardo","family":"Cristofani","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Barbara","family":"Tedesco","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Veronica","family":"Ferrari","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marta","family":"Chierichetti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marta","family":"Cozzi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Paola","family":"Pramaggiore","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Laura","family":"Cornaggia","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ali","family":"Mohamed","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elena","family":"Casarotto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maria","family":"Brodnanova","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rocio","family":"Magdalena","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Prashant","family":"Koshal","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Margherita","family":"Piccolella","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Valeria","family":"Crippa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mariarita","family":"Galbiati","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Angelo","family":"Poletti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Paola","family":"Rusmini","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,7,17]]},"reference":[{"key":"2351_CR1","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1016\/j.yexcr.2014.10.002","volume":"331","author":"A Naderi","year":"2015","unstructured":"Naderi A. Coagulation factor VII is regulated by androgen receptor in breast cancer. Exp Cell Res. 2015;331:239\u201350.","journal-title":"Exp Cell Res"},{"key":"2351_CR2","doi-asserted-by":"publisher","first-page":"1707","DOI":"10.1002\/jcsm.13251","volume":"14","author":"K Ghaibour","year":"2023","unstructured":"Ghaibour K, Schuh M, Souali-Crespo S, et al. Androgen receptor coordinates muscle metabolic and contractile functions. J Cachexia Sarcopenia Muscle. 2023;14:1707\u201320.","journal-title":"J Cachexia Sarcopenia Muscle"},{"key":"2351_CR3","doi-asserted-by":"publisher","first-page":"537","DOI":"10.1007\/BF02738830","volume":"3","author":"M-N Dieudonne","year":"1995","unstructured":"Dieudonne M-N, Pecquery R, Leneveu M-C, Jaubert A-M, Giudicelli Y. Androgen receptors in cultured rat adipose precursor cells during proliferation and differentiation: regional specificities and regulation by testosterone. Endocrine. 1995;3:537\u201341.","journal-title":"Endocrine"},{"key":"2351_CR4","doi-asserted-by":"publisher","first-page":"102303","DOI":"10.1016\/j.isci.2021.102303","volume":"24","author":"I Sakakibara","year":"2021","unstructured":"Sakakibara I, Yanagihara Y, Himori K, et al. Myofiber androgen receptor increases muscle strength mediated by a skeletal muscle splicing variant of Mylk4. iScience. 2021;24:102303.","journal-title":"iScience"},{"key":"2351_CR5","doi-asserted-by":"publisher","first-page":"3493","DOI":"10.1210\/jcem.82.10.4319","volume":"82","author":"EO Abu","year":"1997","unstructured":"Abu EO, Horner A, Kusec V, Triffitt JT, Compston JE. The localization of androgen receptors in human bone. J Clin Endocrinol Metab. 1997;82:3493\u20137.","journal-title":"J Clin Endocrinol Metab"},{"key":"2351_CR6","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1677\/joe.0.1700027","volume":"170","author":"S Bhasin","year":"2001","unstructured":"Bhasin S, Woodhouse L, Storer TW. Proof of the effect of testosterone on skeletal muscle. J Endocrinol. 2001;170:27\u201338.","journal-title":"J Endocrinol"},{"key":"2351_CR7","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1093\/nar\/gng042","volume":"31","author":"SD Mooney","year":"2003","unstructured":"Mooney SD, Klein TE, Altman RB, Trifiro MA, Gottlieb B. A functional analysis of disease-associated mutations in the androgen receptor gene. Nucleic Acids Res. 2003;31:1\u20135.","journal-title":"Nucleic Acids Res"},{"key":"2351_CR8","doi-asserted-by":"crossref","unstructured":"Beitel LK, Alvarado C, Mokhtar S, Paliouras M, Trifiro M. Mechanisms mediating spinal and bulbar muscular atrophy: investigations into polyglutamine-expanded androgen receptor function and dysfunction. Front Neurol. 2013;4.","DOI":"10.3389\/fneur.2013.00053"},{"key":"2351_CR9","doi-asserted-by":"publisher","first-page":"18","DOI":"10.2174\/138920209787581307","volume":"10","author":"G Brooke","year":"2009","unstructured":"Brooke G, Bevan C. The role of androgen receptor mutations in prostate cancer progression. Curr Genomics. 2009;10:18\u201325.","journal-title":"Curr Genomics"},{"key":"2351_CR10","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1093\/brain\/112.1.209","volume":"112","author":"G Sobue","year":"1989","unstructured":"Sobue G, Hashizume Y, Mukai E, Hirayama M, Mitsuma T, Takahashi A. X-linked recessive bulbospinal neuronopathy. A clinicopathological study. Brain. 1989;112(Pt):209\u201332.","journal-title":"Brain"},{"key":"2351_CR11","doi-asserted-by":"publisher","first-page":"928","DOI":"10.1007\/s13311-019-00790-9","volume":"16","author":"FJ Arnold","year":"2019","unstructured":"Arnold FJ, Merry DE. Molecular mechanisms and therapeutics for sbma\/kennedy\u2019s disease. Neurotherapeutics. 2019;16:928\u201347.","journal-title":"Neurotherapeutics"},{"key":"2351_CR12","doi-asserted-by":"publisher","first-page":"671","DOI":"10.1212\/WNL.18.7.671","volume":"18","author":"WR Kennedy","year":"1968","unstructured":"Kennedy WR, Alter M, Sung JH. Progressive proximal spinal and bulbar muscular atrophy of late onset. A sex-linked recessive trait. Neurology. 1968;18:671\u201380.","journal-title":"Neurology"},{"key":"2351_CR13","doi-asserted-by":"publisher","first-page":"100495","DOI":"10.1016\/j.ensci.2024.100495","volume":"34","author":"DJ Bellai","year":"2024","unstructured":"Bellai DJ, Rae MG. A systematic review of the association between the age of onset of spinal bulbar muscular atrophy (Kennedy\u2019s disease) and the length of CAG repeats in the androgen receptor gene. eNeurologicalSci. 2024;34:100495.","journal-title":"eNeurologicalSci"},{"key":"2351_CR14","doi-asserted-by":"publisher","first-page":"1458","DOI":"10.1212\/01.WNL.0000158617.41819.F3","volume":"64","author":"A Echaniz-Laguna","year":"2005","unstructured":"Echaniz-Laguna A, Rousso E, Anheim M, Coss\u00e9e M, Tranchant C. A family with early-onset and rapidly progressive X-linked spinal and bulbar muscular atrophy. Neurology. 2005;64:1458\u201360.","journal-title":"Neurology"},{"key":"2351_CR15","doi-asserted-by":"publisher","first-page":"e84","DOI":"10.1212\/WNL.0000000000201342","volume":"100","author":"R Torii","year":"2023","unstructured":"Torii R, Hashizume A, Yamada S, et al. Clinical features of female carriers and prodromal male patients with spinal and bulbar muscular atrophy. Neurology. 2023;100:e84\u201393.","journal-title":"Neurology"},{"key":"2351_CR16","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1016\/S0960-8966(99)00132-7","volume":"10","author":"C Mariotti","year":"2000","unstructured":"Mariotti C, Castellotti B, Pareyson D, et al. Phenotypic manifestations associated with CAG-repeat expansion in the androgen receptor gene in male patients and heterozygous females: a clinical and molecular study of 30 families. Neuromuscul Disord. 2000;10:391\u20137.","journal-title":"Neuromuscul Disord"},{"key":"2351_CR17","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1016\/j.nmd.2021.11.007","volume":"32","author":"KI M\u00fcller","year":"2022","unstructured":"M\u00fcller KI, Nilssen \u00d8, Nebuchenykh M, L\u00f8seth S, Jonsrud C, Hoem G, Van Ghelue M, Arntzen KA. Kennedy disease in two sisters with biallelic CAG expansions of the androgen receptor gene. Neuromuscul Disord. 2022;32:75\u20139.","journal-title":"Neuromuscul Disord"},{"key":"2351_CR18","doi-asserted-by":"publisher","first-page":"770","DOI":"10.1212\/WNL.59.5.770","volume":"59","author":"BJ Schmidt","year":"2002","unstructured":"Schmidt BJ, Greenberg CR, Allingham\u2013Hawkins DJ, Spriggs EL. Expression of X-linked bulbospinal muscular atrophy (Kennedy disease) in two homozygous women. Neurology. 2002;59:770\u20132.","journal-title":"Neurology"},{"key":"2351_CR19","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1038\/352077a0","volume":"352","author":"AR La Spada","year":"1991","unstructured":"La Spada AR, Wilson EM, Lubahn DB, Harding AE, Fischbeck KH. Androgen receptor gene mutations in X-linked spinal and bulbar muscular atrophy. Nature. 1991;352:77\u20139.","journal-title":"Nature"},{"key":"2351_CR20","doi-asserted-by":"crossref","unstructured":"Ross CA, Poirier MA. Protein aggregation and neurodegenerative disease. Nat Med. 2004;10 Suppl:S10-7.","DOI":"10.1038\/nm1066"},{"key":"2351_CR21","doi-asserted-by":"publisher","first-page":"479","DOI":"10.1016\/S1471-4914(01)02179-7","volume":"7","author":"RL Margolis","year":"2001","unstructured":"Margolis RL, Ross CA. Expansion explosion: new clues to the pathogenesis of repeat expansion neurodegenerative diseases. Trends Mol Med. 2001;7:479\u201382.","journal-title":"Trends Mol Med"},{"key":"2351_CR22","doi-asserted-by":"crossref","unstructured":"DiFiglia M, Sapp E, Chase KO, Davies SW, Bates GP, Vonsattel JP, Aronin N. Aggregation of Huntingtin in Neuronal Intranuclear Inclusions and Dystrophic Neurites in Brain. Science. 1997;277:1990\u201393.","DOI":"10.1126\/science.277.5334.1990"},{"key":"2351_CR23","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1006\/nbdi.1998.0168","volume":"4","author":"MW Becher","year":"1998","unstructured":"Becher MW, Kotzuk JA, Sharp AH, Davies SW, Bates GP, Price DL, Ross CA. Intranuclear neuronal inclusions in huntington\u2019s disease and dentatorubral and pallidoluysian atrophy: correlation between the density of inclusions andIT15CAG triplet repeat length. Neurobiol Dis. 1998;4:387\u201397.","journal-title":"Neurobiol Dis"},{"key":"2351_CR24","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1016\/S0896-6273(00)80943-5","volume":"19","author":"HL Paulson","year":"1997","unstructured":"Paulson HL, Perez MK, Trottier Y, Trojanowski JQ, Subramony SH, Das SS, Vig P, Mandel J-L, Fischbeck KH, Pittman RN. Intranuclear inclusions of expanded polyglutamine protein in spinocerebellar ataxia type 3. Neuron. 1997;19:333\u201344.","journal-title":"Neuron"},{"key":"2351_CR25","doi-asserted-by":"publisher","first-page":"939","DOI":"10.1016\/S0092-8674(00)81200-3","volume":"93","author":"JM Warrick","year":"1998","unstructured":"Warrick JM, Paulson HL, Gray-Board GL, Bui QT, Fischbeck KH, Pittman RN, Bonini NM. Expanded polyglutamine protein forms nuclear inclusions and causes neural degeneration in drosophila. Cell. 1998;93:939\u201349.","journal-title":"Cell"},{"key":"2351_CR26","doi-asserted-by":"publisher","first-page":"520","DOI":"10.1002\/ana.20735","volume":"59","author":"H Banno","year":"2006","unstructured":"Banno H, Adachi H, Katsuno M, Suzuki K, Atsuta N, Watanabe H, Tanaka F, Doyu M, Sobue G. Mutant androgen receptor accumulation in spinal and bulbar muscular atrophy scrotal skin: a pathogenic marker. Ann Neurol. 2006;59:520\u20136.","journal-title":"Ann Neurol"},{"key":"2351_CR27","doi-asserted-by":"publisher","first-page":"246","DOI":"10.1016\/j.pneurobio.2012.05.007","volume":"99","author":"M Katsuno","year":"2012","unstructured":"Katsuno M, Tanaka F, Adachi H, Banno H, Suzuki K, Watanabe H, Sobue G. Pathogenesis and therapy of spinal and bulbar muscular atrophy (SBMA). Prog Neurobiol. 2012;99:246\u201356.","journal-title":"Prog Neurobiol"},{"key":"2351_CR28","doi-asserted-by":"crossref","unstructured":"Paine H. Does loss of the normal protein function contribute to the pathogenesis of huntington\u2019s disease? Bioscience Horizons: Int J Student Res. 2015;8:hzv005.","DOI":"10.1093\/biohorizons\/hzv005"},{"key":"2351_CR29","doi-asserted-by":"publisher","first-page":"521","DOI":"10.1016\/j.tins.2008.07.004","volume":"31","author":"AJ Williams","year":"2008","unstructured":"Williams AJ, Paulson HL. Polyglutamine neurodegeneration: protein misfolding revisited. Trends Neurosci. 2008;31:521\u20138.","journal-title":"Trends Neurosci"},{"key":"2351_CR30","doi-asserted-by":"publisher","first-page":"2225","DOI":"10.1093\/hmg\/ddl148","volume":"15","author":"PS Thomas","year":"2006","unstructured":"Thomas PS, Fraley GS, Damian V, Damien V, Woodke LB, Zapata F, Sopher BL, Plymate SR, La Spada AR. Loss of endogenous androgen receptor protein accelerates motor neuron degeneration and accentuates androgen insensitivity in a mouse model of X-linked spinal and bulbar muscular atrophy. Hum Mol Genet. 2006;15:2225\u201338.","journal-title":"Hum Mol Genet"},{"key":"2351_CR31","doi-asserted-by":"publisher","first-page":"561","DOI":"10.1089\/neu.2007.0466","volume":"25","author":"KN Fargo","year":"2008","unstructured":"Fargo KN, Alexander TD, Tanzer L, Poletti A, Jones KJ. Androgen regulates neuritin mRNA levels in an in vivo model of steroid-enhanced peripheral nerve regeneration. J Neurotrauma. 2008;25:561\u20136.","journal-title":"J Neurotrauma"},{"key":"2351_CR32","doi-asserted-by":"crossref","unstructured":"Vegeto E, Villa A, Della Torre S, Crippa V, Rusmini P, Cristofani R, Galbiati M, Maggi A, Poletti A. The role of sex and sex hormones in neurodegenerative diseases. Endocr Rev. 2020;41:273\u2013319.","DOI":"10.1210\/endrev\/bnz005"},{"key":"2351_CR33","doi-asserted-by":"publisher","first-page":"810","DOI":"10.1136\/jnnp-2015-311305","volume":"87","author":"G Querin","year":"2016","unstructured":"Querin G, Bertolin C, Da Re E, et al. Non-neural phenotype of spinal and bulbar muscular atrophy: results from a large cohort of Italian patients. J Neurol Neurosurg Psychiatry. 2016;87:810\u20136.","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"2351_CR34","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1016\/j.jns.2007.08.012","volume":"264","author":"G Soraru","year":"2008","unstructured":"Soraru G, D\u2019Ascenzo C, Polo A, Palmieri A, Baggio L, Vergani L, Gellera C, Moretto G, Pegoraro E, Angelini C. Spinal and bulbar muscular atrophy: skeletal muscle pathology in male patients and heterozygous females. J Neurol Sci. 2008;264:100\u20135.","journal-title":"J Neurol Sci"},{"key":"2351_CR35","doi-asserted-by":"publisher","first-page":"971","DOI":"10.1016\/0092-8674(93)90585-E","volume":"72","author":"ME MacDonald","year":"1993","unstructured":"MacDonald ME, Ambrose CM, Duyao MP, et al. A novel gene containing a trinucleotide repeat that is expanded and unstable on huntington\u2019s disease chromosomes. Cell. 1993;72:971\u201383.","journal-title":"Cell"},{"key":"2351_CR36","doi-asserted-by":"publisher","first-page":"128","DOI":"10.3390\/brainsci7100128","volume":"7","author":"T Takeuchi","year":"2017","unstructured":"Takeuchi T, Nagai Y. Protein misfolding and aggregation as a therapeutic target for polyglutamine diseases. Brain Sci. 2017;7:128.","journal-title":"Brain Sci"},{"key":"2351_CR37","doi-asserted-by":"publisher","first-page":"2663","DOI":"10.1172\/JCI28773.","volume":"116","author":"Z Yu","year":"2006","unstructured":"Yu Z, Dadgar N, Albertelli M, Gruis K, Jordan C, Robins DM, Lieberman AP. Androgen-dependent pathology demonstrates myopathic contribution to the Kennedy disease phenotype in a mouse knock-in model. J Clin Invest. 2006;116:2663\u201372.","journal-title":"J Clin Invest"},{"key":"2351_CR38","doi-asserted-by":"publisher","first-page":"18259","DOI":"10.1073\/pnas.0705501104","volume":"104","author":"DA Monks","year":"2007","unstructured":"Monks DA, Johansen JA, Mo K, Rao P, Eagleson B, Yu Z, Lieberman AP, Breedlove SM, Jordan CL. Overexpression of wild-type androgen receptor in muscle recapitulates polyglutamine disease. Proc Natl Acad Sci U S A. 2007;104:18259\u201364.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"2351_CR39","doi-asserted-by":"publisher","first-page":"774","DOI":"10.1016\/j.celrep.2014.02.008","volume":"7","author":"AP Lieberman","year":"2014","unstructured":"Lieberman AP, Yu Z, Murray S, et al. Peripheral androgen receptor gene suppression rescues disease in mouse models of spinal and bulbar muscular atrophy. Cell Rep. 2014;7:774\u201384.","journal-title":"Cell Rep"},{"key":"2351_CR40","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1016\/j.neuron.2014.03.001","volume":"82","author":"CJ Cortes","year":"2014","unstructured":"Cortes CJ, Ling SC, Guo LT, et al. Muscle expression of mutant androgen receptor accounts for systemic and motor neuron disease phenotypes in spinal and bulbar muscular atrophy. Neuron. 2014;82:295\u2013307.","journal-title":"Neuron"},{"key":"2351_CR41","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1186\/s40478-023-01582-1","volume":"11","author":"A Gromova","year":"2023","unstructured":"Gromova A, Cha B, Robinson EM, Strickland LM, Nguyen N, ElMallah MK, Cortes CJ, La Spada AR. X-linked SBMA model mice display relevant non-neurological phenotypes and their expression of mutant androgen receptor protein in motor neurons is not required for neuromuscular disease. Acta Neuropathol Commun. 2023;11:90.","journal-title":"Acta Neuropathol Commun"},{"key":"2351_CR42","first-page":"264","volume":"44","author":"CJ Brown","year":"1989","unstructured":"Brown CJ, Goss SJ, Lubahn DB, Joseph DR, Wilson EM, French FS, Willard HF. Androgen receptor locus on the human X chromosome: regional localization to Xq11-12 and description of a DNA polymorphism. Am J Hum Genet. 1989;44:264\u20139.","journal-title":"Am J Hum Genet"},{"key":"2351_CR43","doi-asserted-by":"publisher","first-page":"3360","DOI":"10.1021\/bi702221e","volume":"47","author":"DN Lavery","year":"2008","unstructured":"Lavery DN, McEwan IJ. Structural characterization of the native NH2-terminal transactivation domain of the human androgen receptor: a collapsed disordered conformation underlies structural plasticity and protein-induced folding. Biochemistry. 2008;47:3360\u20139.","journal-title":"Biochemistry"},{"key":"2351_CR44","first-page":"3","volume":"37","author":"RA Davey","year":"2016","unstructured":"Davey RA, Grossmann M. Androgen receptor structure, function and biology: from bench to bedside. Clin Biochem Rev. 2016;37:3\u201315.","journal-title":"Clin Biochem Rev"},{"key":"2351_CR45","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.mce.2012.02.019","volume":"358","author":"L Clinckemalie","year":"2012","unstructured":"Clinckemalie L, Vanderschueren D, Boonen S, Claessens F. The hinge region in androgen receptor control. Mol Cell Endocrinol. 2012;358:1\u20138.","journal-title":"Mol Cell Endocrinol"},{"key":"2351_CR46","doi-asserted-by":"publisher","first-page":"13115","DOI":"10.1016\/S0021-9258(17)36806-0","volume":"269","author":"ZX Zhou","year":"1994","unstructured":"Zhou ZX, Sar M, Simental JA, Lane MV, Wilson EM. A ligand-dependent bipartite nuclear targeting signal in the human androgen receptor. Requirement for the DNA-binding domain and modulation by NH2-terminal and carboxyl-terminal sequences. J Biol Chem. 1994;269:13115\u201323.","journal-title":"J Biol Chem"},{"key":"2351_CR47","doi-asserted-by":"publisher","first-page":"1919","DOI":"10.1007\/s00018-010-0302-1","volume":"67","author":"TM Tanner","year":"2010","unstructured":"Tanner TM, Denayer S, Geverts B, et al. A 629RKLKK633 motif in the hinge region controls the androgen receptor at multiple levels. Cell Mol Life Sci. 2010;67:1919\u201327.","journal-title":"Cell Mol Life Sci"},{"key":"2351_CR48","doi-asserted-by":"publisher","first-page":"25631","DOI":"10.1074\/jbc.M202809200","volume":"277","author":"B He","year":"2002","unstructured":"He B, Lee LW, Minges JT, Wilson EM. Dependence of selective gene activation on the androgen receptor NH2- and COOH-terminal interaction. J Biol Chem. 2002;277:25631\u20139.","journal-title":"J Biol Chem"},{"key":"2351_CR49","doi-asserted-by":"publisher","first-page":"29983","DOI":"10.1074\/jbc.270.50.29983","volume":"270","author":"E Langley","year":"1995","unstructured":"Langley E, Zhou Z, Wilson EM. Evidence for an anti-parallel orientation of the ligand-activated human androgen receptor dimer. J Biol Chem. 1995;270:29983\u201390.","journal-title":"J Biol Chem"},{"key":"2351_CR50","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1074\/jbc.273.1.92","volume":"273","author":"E Langley","year":"1998","unstructured":"Langley E, Kemppainen JA, Wilson EM. Intermolecular NH2-\/Carboxyl-terminal interactions in androgen receptor dimerization revealed by mutations that cause androgen insensitivity. J Biol Chem. 1998;273:92\u2013101.","journal-title":"J Biol Chem"},{"key":"2351_CR51","doi-asserted-by":"publisher","first-page":"403","DOI":"10.1016\/j.mce.2011.03.026","volume":"348","author":"EB Askew","year":"2012","unstructured":"Askew EB, Minges JT, Hnat AT, Wilson EM. Structural features discriminate androgen receptor N\/C terminal and coactivator interactions. Mol Cell Endocrinol. 2012;348:403\u201310.","journal-title":"Mol Cell Endocrinol"},{"key":"2351_CR52","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1016\/S1096-7192(02)00009-4","volume":"75","author":"B He","year":"2002","unstructured":"He B, Wilson EM. The NH2-terminal and carboxyl-terminal interaction in the human androgen receptor. Mol Genet Metab. 2002;75:293\u20138.","journal-title":"Mol Genet Metab"},{"key":"2351_CR53","doi-asserted-by":"publisher","first-page":"4514","DOI":"10.1158\/0008-5472.CAN-06-1701","volume":"67","author":"A Haelens","year":"2007","unstructured":"Haelens A, Tanner T, Denayer S, Callewaert L, Claessens F. The hinge region regulates DNA binding, nuclear translocation, and transactivation of the androgen receptor. Cancer Res. 2007;67:4514\u201323.","journal-title":"Cancer Res"},{"key":"2351_CR54","doi-asserted-by":"publisher","first-page":"9296","DOI":"10.1016\/S0021-9258(18)98349-3","volume":"268","author":"PW Faber","year":"1993","unstructured":"Faber PW, van Rooij HC, Schipper HJ, Brinkmann AO, Trapman J. Two different, overlapping pathways of transcription initiation are active on the TATA-less human androgen receptor promoter. The role of Sp1. J Biol Chem. 1993;268:9296\u2013301.","journal-title":"J Biol Chem"},{"key":"2351_CR55","doi-asserted-by":"publisher","first-page":"657","DOI":"10.1002\/jcb.20460","volume":"95","author":"KL Burnstein","year":"2005","unstructured":"Burnstein KL. Regulation of androgen receptor levels: implications for prostate cancer progression and therapy. J Cell Biochem. 2005;95:657\u201369.","journal-title":"J Cell Biochem"},{"key":"2351_CR56","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1007\/s12672-014-0185-y","volume":"5","author":"CW Hay","year":"2014","unstructured":"Hay CW, Watt K, Hunter I, Lavery DN, MacKenzie A, McEwan IJ. Negative regulation of the androgen receptor gene through a primate-specific androgen response element present in the 5\u2032 UTR. Horm Cancer. 2014;5:299\u2013311.","journal-title":"Horm Cancer"},{"key":"2351_CR57","doi-asserted-by":"publisher","first-page":"25655","DOI":"10.1016\/S0021-9258(18)47299-7","volume":"269","author":"A Mizokami","year":"1994","unstructured":"Mizokami A, Chang C. Induction of translation by the 5\u2019-untranslated region of human androgen receptor mRNA. J Biol Chem. 1994;269:25655\u20139.","journal-title":"J Biol Chem"},{"key":"2351_CR58","doi-asserted-by":"crossref","unstructured":"Yang Y, Liu KY, Liu Q, Cao Q. Androgen receptor-related non-coding RNAs in prostate cancer. Front Cell Dev Biology. 2021;9:660853.","DOI":"10.3389\/fcell.2021.660853"},{"key":"2351_CR59","doi-asserted-by":"publisher","first-page":"819","DOI":"10.1080\/15476286.2022.2084839","volume":"19","author":"E Likos","year":"2022","unstructured":"Likos E, Bhattarai A, Weyman CM, Shukla GC. The androgen receptor messenger RNA: what do we know? RNA Biol. 2022;19:819\u201328.","journal-title":"RNA Biol"},{"key":"2351_CR60","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1002\/pros.1048","volume":"47","author":"A Chlenski","year":"2001","unstructured":"Chlenski A, Nakashiro K, Ketels KV, Korovaitseva GI, Oyasu R. Androgen receptor expression in androgen-independent prostate cancer cell lines. Prostate. 2001;47:66\u201375.","journal-title":"Prostate"},{"key":"2351_CR61","doi-asserted-by":"publisher","first-page":"395","DOI":"10.1016\/j.nbd.2008.11.007","volume":"33","author":"G Vismara","year":"2009","unstructured":"Vismara G, Simonini F, Onesto E, Bignamini M, Miceli V, Martini L, Poletti A. Androgens inhibit androgen receptor promoter activation in motor neurons. Neurobiol Dis. 2009;33:395\u2013404.","journal-title":"Neurobiol Dis"},{"key":"2351_CR62","doi-asserted-by":"publisher","first-page":"1234","DOI":"10.1073\/pnas.91.4.1234","volume":"91","author":"CM Wilson","year":"1994","unstructured":"Wilson CM, McPhaul MJ. A and B forms of the androgen receptor are present in human genital skin fibroblasts. Proc Natl Acad Sci U S A. 1994;91:1234\u20138.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"2351_CR63","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1016\/0303-7207(96)03819-1","volume":"120","author":"CM Wilson","year":"1996","unstructured":"Wilson CM, McPhaul MJ. A and B forms of the androgen receptor are expressed in a variety of human tissues. Mol Cell Endocrinol. 1996;120:51\u20137.","journal-title":"Mol Cell Endocrinol"},{"key":"2351_CR64","first-page":"74","volume":"272","author":"I Ahrens-Fath","year":"2005","unstructured":"Ahrens-Fath I, Politz O, Geserick C, Haendler B. Androgen receptor function is modulated by the tissue-specific AR45 variant. FEBS J. 2005;272:74\u201384.","journal-title":"FEBS J"},{"key":"2351_CR65","doi-asserted-by":"publisher","first-page":"26164","DOI":"10.1074\/jbc.M004571200","volume":"275","author":"PM Matias","year":"2000","unstructured":"Matias PM, Donner P, Coelho R, et al. Structural evidence for ligand specificity in the binding domain of the human androgen receptor: Implication for pathogenic gene mutations. J Biol Chem. 2000;275:26164\u201371.","journal-title":"J Biol Chem"},{"key":"2351_CR66","doi-asserted-by":"crossref","unstructured":"Shaffer PL, Jivan A, Dollins DE, Claessens F, Gewirth DT. Structural basis of androgen receptor binding to selective androgen response elements. Proc Natl Acad Sci U S A. 2004;101:4758\u201363.","DOI":"10.1073\/pnas.0401123101"},{"key":"2351_CR67","doi-asserted-by":"publisher","first-page":"3562","DOI":"10.1038\/s41467-019-11594-y","volume":"10","author":"B Eftekharzadeh","year":"2019","unstructured":"Eftekharzadeh B, Banduseela VC, Chiesa G, et al. Hsp70 and Hsp40 inhibit an inter-domain interaction necessary for transcriptional activity in the androgen receptor. Nat Commun. 2019;10:3562.","journal-title":"Nat Commun"},{"key":"2351_CR68","doi-asserted-by":"publisher","first-page":"2361","DOI":"10.1016\/j.bpj.2016.04.022","volume":"110","author":"B Eftekharzadeh","year":"2016","unstructured":"Eftekharzadeh B, Piai A, Chiesa G, Mungianu D, Garc\u00eda J, Pierattelli R, Felli IC, Salvatella X. Sequence context influences the structure and aggregation behavior of a PolyQ tract. Biophys J. 2016;110:2361\u20136.","journal-title":"Biophys J"},{"key":"2351_CR69","doi-asserted-by":"crossref","unstructured":"Cutress ML, Whitaker HC, Mills IG, Stewart M, Neal DE. Structural basis for the nuclear import of the human androgen receptor. J Cell Sci. 2008;121:957\u201368.","DOI":"10.1242\/jcs.022103"},{"key":"2351_CR70","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1111\/j.1365-2990.2007.00830.x","volume":"33","author":"H Adachi","year":"2007","unstructured":"Adachi H, Waza M, Katsuno M, Tanaka F, Doyu M, Sobue G. Pathogenesis and molecular targeted therapy of spinal and bulbar muscular atrophy. Neuropathol Appl Neurobiol. 2007;33:135\u201351.","journal-title":"Neuropathol Appl Neurobiol"},{"key":"2351_CR71","doi-asserted-by":"crossref","unstructured":"Rusmini P, Sau D, Crippa V, Palazzolo I, Simonini F, Onesto E, Martini L, Poletti A. Aggregation and proteasome: the case of elongated polyglutamine aggregation in spinal and bulbar muscular atrophy. Neurobiol Aging. 2007;8:1099\u20131111.","DOI":"10.1016\/j.neurobiolaging.2006.05.015"},{"key":"2351_CR72","doi-asserted-by":"crossref","unstructured":"Rusmini P, Crippa V, Giorgetti E, Boncoraglio A, Cristofani R, Carra S, Poletti A. Clearance of the mutant androgen receptor in motoneuronal models of spinal and bulbar muscular atrophy. Neurobiol Aging. 2013;34:2585\u2013603.","DOI":"10.1016\/j.neurobiolaging.2013.05.026"},{"key":"2351_CR73","doi-asserted-by":"crossref","unstructured":"Cristofani R, Crippa V, Rusmini P, et al. Inhibition of retrograde transport modulates misfolded protein accumulation and clearance in motoneuron diseases. Autophagy. 2017;3;13:1280\u20131303.","DOI":"10.1080\/15548627.2017.1308985"},{"key":"2351_CR74","doi-asserted-by":"crossref","unstructured":"Rusmini P, Cristofani R, Tedesco B et al. Enhanced clearance of neurotoxic misfolded proteins by the natural compound Berberine and its derivatives. Int J Mol Sci. 2020;21:3443.","DOI":"10.3390\/ijms21103443"},{"key":"2351_CR75","doi-asserted-by":"publisher","first-page":"1194","DOI":"10.4161\/auto.5.8.9726","volume":"5","author":"HL Montie","year":"2009","unstructured":"Montie HL, Merry DE. Autophagy and access: understanding the role of androgen receptor subcellular localization in SBMA. Autophagy. 2009;5:1194\u20137.","journal-title":"Autophagy"},{"key":"2351_CR76","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1038\/s41598-018-36784-4","volume":"9","author":"FJ Arnold","year":"2019","unstructured":"Arnold FJ, Pluciennik A, Merry DE. Impaired nuclear export of polyglutamine-expanded androgen receptor in spinal and bulbar muscular atrophy. Sci Rep. 2019;9:119.","journal-title":"Sci Rep"},{"key":"2351_CR77","doi-asserted-by":"publisher","first-page":"659","DOI":"10.1093\/brain\/awh381","volume":"128","author":"H Adachi","year":"2005","unstructured":"Adachi H, Katsuno M, Minamiyama M, et al. Widespread nuclear and cytoplasmic accumulation of mutant androgen receptor in SBMA patients. Brain. 2005;128:659\u201370.","journal-title":"Brain"},{"key":"2351_CR78","doi-asserted-by":"crossref","unstructured":"Giorgetti E, Rusmini P, Crippa V, Cristofani R, Boncoraglio A, Cicardi ME, et al. Synergic prodegradative activity of bicalutamide and trehalose on the mutant androgen receptor responsible for spinal and bulbar muscular atrophy. Hum Mol Genet. 2015;24:64\u201375.","DOI":"10.1093\/hmg\/ddu419"},{"key":"2351_CR79","doi-asserted-by":"crossref","unstructured":"Rusmini P, Polanco MJ, Cristofani R, et al. Aberrant autophagic response in the muscle of A knock-in mouse model of spinal and bulbar muscular atrophy. Sci Rep. 2015;5:15174.","DOI":"10.1038\/srep15174"},{"key":"2351_CR80","doi-asserted-by":"crossref","unstructured":"Chivet M, Marchioretti C, Pirazzini M, et al. Polyglutamine-expanded androgen receptor alteration of skeletal muscle homeostasis and myonuclear aggregation are affected by sex, age and muscle metabolism. Cells. 2020;9.","DOI":"10.3390\/cells9020325"},{"key":"2351_CR81","doi-asserted-by":"publisher","first-page":"324","DOI":"10.1038\/nature10317","volume":"475","author":"FU Hartl","year":"2011","unstructured":"Hartl FU, Bracher A, Hayer-Hartl M. Molecular chaperones in protein folding and proteostasis. Nature. 2011;475:324\u201332.","journal-title":"Nature"},{"key":"2351_CR82","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1007\/s12192-008-0068-7","volume":"14","author":"HH Kampinga","year":"2009","unstructured":"Kampinga HH, Hageman J, Vos MJ, Kubota H, Tanguay RM, Bruford EA, Cheetham ME, Chen B, Hightower LE. Guidelines for the nomenclature of the human heat shock proteins. Cell Stress Chaperones. 2009;14:105\u201311.","journal-title":"Cell Stress Chaperones"},{"key":"2351_CR83","doi-asserted-by":"publisher","first-page":"7529","DOI":"10.1016\/S0021-9258(19)43857-X","volume":"255","author":"KD Wilkinson","year":"1980","unstructured":"Wilkinson KD, Urban MK, Haas AL. Ubiquitin is the ATP-dependent proteolysis factor I of rabbit reticulocytes. J Biol Chem. 1980;255:7529\u201332.","journal-title":"J Biol Chem"},{"key":"2351_CR84","doi-asserted-by":"crossref","unstructured":"Ciechanover A, Heller H, Elias S, Haas AL, Hershko A. ATP-dependent conjugation of reticulocyte proteins with the polypeptide required for protein degradation. Proc Natl Acad Sci. 1980;77:1365\u20131368.","DOI":"10.1073\/pnas.77.3.1365"},{"key":"2351_CR85","doi-asserted-by":"publisher","first-page":"1100","DOI":"10.1016\/0006-291X(78)91249-4","volume":"81","author":"A Ciehanover","year":"1978","unstructured":"Ciehanover A, Hod Y, Hershko A. A heat-stable polypeptide component of an ATP-dependent proteolytic system from reticulocytes. Biochem Biophys Res Commun. 1978;81:1100\u20135.","journal-title":"Biochem Biophys Res Commun"},{"key":"2351_CR86","doi-asserted-by":"publisher","first-page":"322","DOI":"10.1038\/nrm3982","volume":"16","author":"A Ciechanover","year":"2015","unstructured":"Ciechanover A. The unravelling of the ubiquitin system. Nat Rev Mol Cell Biol. 2015;16:322\u20134.","journal-title":"Nat Rev Mol Cell Biol"},{"key":"2351_CR87","doi-asserted-by":"publisher","first-page":"1102","DOI":"10.1038\/ncb1007-1102","volume":"9","author":"Z Xie","year":"2007","unstructured":"Xie Z, Klionsky DJ. Autophagosome formation: core machinery and adaptations. Nat Cell Biol. 2007;9:1102\u20139.","journal-title":"Nat Cell Biol"},{"key":"2351_CR88","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1016\/j.cub.2009.11.022","volume":"20","author":"V Arndt","year":"2010","unstructured":"Arndt V, Dick N, Tawo R, et al. Chaperone-assisted selective autophagy is essential for muscle maintenance. Curr Biol. 2010;20:143\u20138.","journal-title":"Curr Biol"},{"key":"2351_CR89","doi-asserted-by":"crossref","unstructured":"Crippa V, Sau D, Rusmini P, et al. The small heat shock protein B8 (HspB8) promotes autophagic removal of misfolded proteins involved in amyotrophic lateral sclerosis (ALS). Hum Mol Genet. 2010;19:3440\u20133456.","DOI":"10.1093\/hmg\/ddq257"},{"key":"2351_CR90","doi-asserted-by":"publisher","first-page":"889","DOI":"10.1038\/emboj.2009.29","volume":"28","author":"M Gamerdinger","year":"2009","unstructured":"Gamerdinger M, Hajieva P, Kaya AM, Wolfrum U, Hartl FU, Behl C. Protein quality control during aging involves recruitment of the macroautophagy pathway by BAG3. EMBO J. 2009;28:889\u2013901.","journal-title":"EMBO J"},{"key":"2351_CR91","doi-asserted-by":"publisher","first-page":"185","DOI":"10.3389\/fnins.2017.00185","volume":"11","author":"A Ciechanover","year":"2017","unstructured":"Ciechanover A, Kwon YT. Protein quality control by molecular chaperones in neurodegeneration. Front Neurosci. 2017;11:185.","journal-title":"Front Neurosci"},{"key":"2351_CR92","doi-asserted-by":"publisher","first-page":"bvab035","DOI":"10.1210\/jendso\/bvab035","volume":"5","author":"O Astapova","year":"2021","unstructured":"Astapova O, Seger C, Hammes SR. Ligand binding prolongs androgen receptor protein half-life by reducing its degradation. J Endocr Soc. 2021;5:bvab035\u2013035.","journal-title":"J Endocr Soc"},{"key":"2351_CR93","first-page":"208","volume":"9","author":"ZX Zhou","year":"1995","unstructured":"Zhou ZX, Lane MV, Kemppainen JA, French FS, Wilson EM. Specificity of ligand-dependent androgen receptor stabilization: receptor domain interactions influence ligand dissociation and receptor stability. Mol Endocrinol. 1995;9:208\u201318.","journal-title":"Mol Endocrinol"},{"key":"2351_CR94","doi-asserted-by":"publisher","first-page":"968","DOI":"10.1016\/S0021-9258(18)48380-9","volume":"267","author":"JA Kemppainen","year":"1992","unstructured":"Kemppainen JA, Lane MV, Sar M, Wilson EM. Androgen receptor phosphorylation, turnover, nuclear transport, and transcriptional activation. Specificity for steroids and antihormones. J Biol Chem. 1992;267:968\u201374.","journal-title":"J Biol Chem"},{"key":"2351_CR95","doi-asserted-by":"publisher","first-page":"455","DOI":"10.1016\/S0021-9258(18)89753-8","volume":"260","author":"AJ Syms","year":"1985","unstructured":"Syms AJ, Norris JS, Panko WB, Smith RG. Mechanism of androgen-receptor augmentation. Analysis of receptor synthesis and degradation by the density-shift technique. J Biol Chem. 1985;260:455\u201361.","journal-title":"J Biol Chem"},{"key":"2351_CR96","unstructured":"Gregory CW, Johnson RT, Mohler JL, French FS, Wilson EM. Androgen receptor stabilization in recurrent prostate cancer is associated with hypersensitivity to low androgen. Cancer Res. 2001;61:2892\u20132898."},{"key":"2351_CR97","doi-asserted-by":"publisher","first-page":"779","DOI":"10.1016\/S0006-291X(02)00564-8","volume":"294","author":"T Furutani","year":"2002","unstructured":"Furutani T, Watanabe T, Tanimoto K, Hashimoto T, Koutoku H, Kudoh M, Shimizu Y, Kato S, Shikama H. Stabilization of androgen receptor protein is induced by agonist, not by antagonists. Biochem Biophys Res Commun. 2002;294:779\u201384.","journal-title":"Biochem Biophys Res Commun"},{"key":"2351_CR98","doi-asserted-by":"publisher","first-page":"26321","DOI":"10.1074\/jbc.M203310200","volume":"277","author":"D Masiello","year":"2002","unstructured":"Masiello D, Cheng S, Bubley GJ, Lu ML, Balk SP. Bicalutamide functions as an androgen receptor antagonist by assembly of a transcriptionally inactive receptor. J Biol Chem. 2002;277:26321\u20136.","journal-title":"J Biol Chem"},{"key":"2351_CR99","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1016\/0303-7207(86)90132-2","volume":"44","author":"J Simard","year":"1986","unstructured":"Simard J, Luthy I, Guay J, B\u00e9langer A, Labrie F. Characteristics of interaction of the antiandrogen flutamide with the androgen receptor in various target tissues. Mol Cell Endocrinol. 1986;44:261\u201370.","journal-title":"Mol Cell Endocrinol"},{"key":"2351_CR100","doi-asserted-by":"crossref","unstructured":"Tran C, Ouk S, Clegg NJ, Chen Y, Watson PA, Arora V, et al. Development of a second-generation antiandrogen for treatment of advanced prostate cancer. Science. 2009;324:787\u2013790.","DOI":"10.1126\/science.1168175"},{"key":"2351_CR101","doi-asserted-by":"crossref","unstructured":"Erb HHH, Oster MA, Gelbrich N, Cammann C, Thomas C, Mustea A, Stope MB. Enzalutamide-induced proteolytic degradation of the androgen receptor in prostate cancer cells is mediated only to a limited extent by the proteasome system. Anticancer Res. 2021;41:3271\u20133279.","DOI":"10.21873\/anticanres.15113"},{"key":"2351_CR102","doi-asserted-by":"publisher","first-page":"144","DOI":"10.1006\/bbrc.2000.3424","volume":"276","author":"L Sheflin","year":"2000","unstructured":"Sheflin L, Keegan B, Zhang W, Spaulding SW. Inhibiting proteasomes in human HepG2 and LNCaP cells increases endogenous androgen receptor levels. Biochem Biophys Res Commun. 2000;276:144\u201350.","journal-title":"Biochem Biophys Res Commun"},{"key":"2351_CR103","doi-asserted-by":"crossref","unstructured":"Qi J, Fan L, Hussain A. Implications of ubiquitin ligases in castration-resistant prostate cancer. Curr Opin Oncol. 2015;27:172\u201376.","DOI":"10.1097\/CCO.0000000000000178"},{"key":"2351_CR104","doi-asserted-by":"crossref","unstructured":"Van der Steen T, Tindall DJ, Huang H. Posttranslational modification of the androgen receptor in prostate cancer. Int J Mol Sci. 2013;14:14833\u201359.","DOI":"10.3390\/ijms140714833"},{"key":"2351_CR105","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1038\/onc.2012.561","volume":"33","author":"S Sarkar","year":"2014","unstructured":"Sarkar S, Brautigan DL, Parsons SJ, Larner JM. Androgen receptor degradation by the E3 ligase CHIP modulates mitotic arrest in prostate cancer cells. Oncogene. 2014;33:26\u201333.","journal-title":"Oncogene"},{"key":"2351_CR106","doi-asserted-by":"publisher","first-page":"657","DOI":"10.1016\/j.celrep.2014.01.013","volume":"6","author":"J An","year":"2014","unstructured":"An J, Wang C, Deng Y, Yu L, Huang H. Destruction of full-length androgen receptor by wild-type SPOP, but not prostate-cancer-associated mutants. Cell Rep. 2014;6:657\u201369.","journal-title":"Cell Rep"},{"key":"2351_CR107","doi-asserted-by":"publisher","first-page":"4037","DOI":"10.1093\/emboj\/cdf406","volume":"21","author":"H-K Lin","year":"2002","unstructured":"Lin H-K, Wang L, Hu Y-C, Altuwaijri S, Chang C. Phosphorylation-dependent ubiquitylation and degradation of androgen receptor by Akt require Mdm2 E3 ligase. EMBO J. 2002;21:4037\u201348.","journal-title":"EMBO J"},{"key":"2351_CR108","doi-asserted-by":"crossref","unstructured":"Koryakina Y, Ta HQ, Gioeli D. Androgen receptor phosphorylation: biological context and functional consequences. Endocr Relat Cancer. 2014;21:T131\u201345.","DOI":"10.1530\/ERC-13-0472"},{"key":"2351_CR109","doi-asserted-by":"publisher","first-page":"861","DOI":"10.1038\/nrm3011","volume":"11","author":"JR Gareau","year":"2010","unstructured":"Gareau JR, Lima CD. The SUMO pathway: emerging mechanisms that shape specificity, conjugation and recognition. Nat Rev Mol Cell Biol. 2010;11:861\u201371.","journal-title":"Nat Rev Mol Cell Biol"},{"key":"2351_CR110","doi-asserted-by":"crossref","unstructured":"Poukka H, Karvonen U, J\u00e4nne OA, Palvimo JJ. Covalent modification of the androgen receptor by small ubiquitin-like modifier 1 (SUMO-1). Proc Natl Acad Sci. 2000;97:14145\u201350.","DOI":"10.1073\/pnas.97.26.14145"},{"key":"2351_CR111","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1186\/s12964-019-0457-9","volume":"17","author":"N Yang","year":"2019","unstructured":"Yang N, Liu S, Qin T, Liu X, Watanabe N, Mayo KH, Li J, Li X. SUMO3 modification by PIAS1 modulates androgen receptor cellular distribution and stability. Cell Comm Sig. 2019;17:153.","journal-title":"Cell Communication Signal"},{"key":"2351_CR112","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1007\/978-3-319-11731-7_11","volume":"78","author":"AL Edkins","year":"2015","unstructured":"Edkins AL. CHIP: a co-chaperone for degradation by the proteasome. Subcell Biochem. 2015;78:219\u201342.","journal-title":"Subcell Biochem"},{"key":"2351_CR113","doi-asserted-by":"publisher","first-page":"30643","DOI":"10.1074\/jbc.M403117200","volume":"279","author":"B He","year":"2004","unstructured":"He B, Bai S, Hnat AT, Kalman RI, Minges JT, Patterson C, Wilson EM. An androgen receptor NH2-terminal conserved motif interacts with the COOH terminus of the Hsp70-interacting protein (CHIP) *. J Biol Chem. 2004;279:30643\u201353.","journal-title":"J Biol Chem"},{"key":"2351_CR114","doi-asserted-by":"publisher","first-page":"1994","DOI":"10.1016\/j.cellsig.2015.07.009","volume":"27","author":"T Mitani","year":"2015","unstructured":"Mitani T, Minami M, Harada N, Ashida H, Yamaji R. Autophagic degradation of the androgen receptor mediated by increased phosphorylation of p62 suppresses apoptosis in hypoxia. Cell Signal. 2015;27:1994\u20132001.","journal-title":"Cell Signal"},{"key":"2351_CR115","doi-asserted-by":"publisher","first-page":"184","DOI":"10.1038\/ng1093-184","volume":"5","author":"AN Mhatre","year":"1993","unstructured":"Mhatre AN, Trifiro MA, Kaufman M, Kazemi-Esfarjani P, Figlewicz D, Rouleau G, Pinsky L. Reduced transcriptional regulatory competence of the androgen receptor in X\u2013linked spinal and bulbar muscular atrophy. Nat Genet. 1993;5:184\u20138.","journal-title":"Nat Genet"},{"key":"2351_CR116","doi-asserted-by":"publisher","first-page":"523","DOI":"10.1093\/hmg\/4.4.523","volume":"4","author":"P Kazemi-Esfarjani","year":"1995","unstructured":"Kazemi-Esfarjani P, Trifiro MA, Pinsky L. Evidence for a repressive function of the long polyglutamine tract in the human androgen receptor: possible pathogenetic relevance for the (CAG)n-expanded neuronopathies. Hum Mol Genet. 1995;4:523\u20137.","journal-title":"Hum Mol Genet"},{"key":"2351_CR117","first-page":"3777","volume":"82","author":"TG Tut","year":"1997","unstructured":"Tut TG, Ghadessy FJ, Trifiro MA, Pinsky L, Yong EL. Long polyglutamine tracts in the androgen receptor are associated with reduced trans-activation, impaired sperm production, and male Infertility1. J Clin Endocrinol Metab. 1997;82:3777\u201382.","journal-title":"J Clin Endocrinol Metab"},{"key":"2351_CR118","first-page":"134","volume":"3","author":"S Belikov","year":"2015","unstructured":"Belikov S, Bott LC, Fischbeck KH, Wrange \u00d6. The polyglutamine-expanded androgen receptor has increased DNA binding and reduced transcriptional activity. Biochem Biophys Rep. 2015;3:134\u20139.","journal-title":"Biochem Biophys Rep"},{"key":"2351_CR119","doi-asserted-by":"publisher","first-page":"1967","DOI":"10.1093\/hmg\/11.17.1967","volume":"11","author":"AP Lieberman","year":"2002","unstructured":"Lieberman AP, Harmison G, Strand AD, Olson JM, Fischbeck KH. Altered transcriptional regulation in cells expressing the expanded polyglutamine androgen receptor. Hum Mol Genet. 2002;11:1967\u201376.","journal-title":"Hum Mol Genet"},{"key":"2351_CR120","doi-asserted-by":"publisher","first-page":"1937","DOI":"10.1093\/hmg\/ddp115","volume":"18","author":"HL Montie","year":"2009","unstructured":"Montie HL, Cho MS, Holder L, Liu Y, Tsvetkov AS, Finkbeiner S, Merry DE. Cytoplasmic retention of polyglutamine-expanded androgen receptor ameliorates disease via autophagy in a mouse model of spinal and bulbar muscular atrophy. Hum Mol Genet. 2009;18:1937\u201350.","journal-title":"Hum Mol Genet"},{"key":"2351_CR121","doi-asserted-by":"publisher","first-page":"936","DOI":"10.1016\/j.neuron.2010.08.034","volume":"67","author":"NB Nedelsky","year":"2010","unstructured":"Nedelsky NB, Pennuto M, Smith RB, Palazzolo I, Moore J, Nie Z, Neale G, Taylor JP. Native functions of the androgen receptor are essential to pathogenesis in a Drosophila model of spinobulbar muscular atrophy. Neuron. 2010;67:936\u201352.","journal-title":"Neuron"},{"key":"2351_CR122","doi-asserted-by":"crossref","unstructured":"Orr CR, Montie HL, Liu Y, Bolzoni E, Jenkins SC, Wilson EM, Joseph JD, McDonnell DP, Merry DE. An interdomain interaction of the androgen receptor is required for its aggregation and toxicity in spinal and bulbar muscular atrophy. J Biol Chem. 2010;285:35567\u201377.","DOI":"10.1074\/jbc.M110.146845"},{"key":"2351_CR123","doi-asserted-by":"publisher","first-page":"2312","DOI":"10.1016\/j.celrep.2015.11.019","volume":"13","author":"L Zboray","year":"2015","unstructured":"Zboray L, Pluciennik A, Curtis D, et al. Preventing the androgen receptor N\/C interaction delays disease onset in a mouse model of SBMA. Cell Rep. 2015;13:2312\u201323.","journal-title":"Cell Rep"},{"key":"2351_CR124","doi-asserted-by":"crossref","unstructured":"Lisberg A, Liu Y, Merry DE. Blocking the dimerization of polyglutamine-expanded androgen receptor protects cells from DHT-induced toxicity by increasing AR turnover. J Biol Chem. 2024;300:107246.","DOI":"10.1016\/j.jbc.2024.107246"},{"key":"2351_CR125","doi-asserted-by":"publisher","first-page":"ra370181","DOI":"10.1126\/scitranslmed.aaf9526","volume":"8","author":"MJ Polanco","year":"2016","unstructured":"Polanco MJ, Parodi S, Piol D, et al. Adenylyl cyclase activating polypeptide reduces phosphorylation and toxicity of the polyglutamine-expanded androgen receptor in spinobulbar muscular atrophy. Sci Transl Med. 2016;8:ra370181\u2013370181.","journal-title":"Sci Transl Med"},{"key":"2351_CR126","doi-asserted-by":"publisher","first-page":"eade1694","DOI":"10.1126\/sciadv.ade1694","volume":"9","author":"D Piol","year":"2023","unstructured":"Piol D, Tosatto L, Zuccaro E, et al. Antagonistic effect of cyclin-dependent kinases and a calcium-dependent phosphatase on polyglutamine-expanded androgen receptor toxic gain of function. Sci Adv. 2023;9:eade1694.","journal-title":"Sci Adv"},{"key":"2351_CR127","doi-asserted-by":"publisher","first-page":"316","DOI":"10.1016\/j.neuron.2009.07.019","volume":"63","author":"I Palazzolo","year":"2009","unstructured":"Palazzolo I, Stack C, Kong L, et al. Overexpression of IGF-1 in muscle attenuates disease in a mouse model of spinal and bulbar muscular atrophy. Neuron. 2009;63:316\u201328.","journal-title":"Neuron"},{"key":"2351_CR128","doi-asserted-by":"publisher","first-page":"e08493","DOI":"10.7554\/eLife.08493","volume":"4","author":"TW Todd","year":"2015","unstructured":"Todd TW, Kokubu H, Miranda HC, Cortes CJ, La Spada AR, Lim J. Nemo-like kinase is a novel regulator of spinal and bulbar muscular atrophy. Elife. 2015;4:e08493.","journal-title":"Elife"},{"key":"2351_CR129","doi-asserted-by":"publisher","first-page":"1088","DOI":"10.1038\/nm1298","volume":"11","author":"M Waza","year":"2005","unstructured":"Waza M, Adachi H, Katsuno M, Minamiyama M, Sang C, Tanaka F, Inukai A, Doyu M, Sobue G. 17-AAG, an Hsp90 inhibitor, ameliorates polyglutamine-mediated motor neuron degeneration. Nat Med. 2005;11:1088\u201395.","journal-title":"Nat Med"},{"key":"2351_CR130","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1016\/j.nbd.2010.08.023","volume":"41","author":"P Rusmini","year":"2011","unstructured":"Rusmini P, Simonini F, Crippa V, Bolzoni E, Onesto E, Cagnin M, Sau D, Ferri N, Poletti A. 17-AAG increases autophagic removal of mutant androgen receptor in spinal and bulbar muscular atrophy. Neurobiol Dis. 2011;41:83\u201395.","journal-title":"Neurobiol Dis"},{"key":"2351_CR131","doi-asserted-by":"publisher","first-page":"898","DOI":"10.1093\/hmg\/ddn419","volume":"18","author":"K Tokui","year":"2009","unstructured":"Tokui K, Adachi H, Waza M, et al. 17-DMAG ameliorates polyglutamine-mediated motor neuron degeneration through well-preserved proteasome function in an SBMA model mouse. Hum Mol Genet. 2009;18:898\u2013910.","journal-title":"Hum Mol Genet"},{"key":"2351_CR132","doi-asserted-by":"publisher","first-page":"4152","DOI":"10.1200\/JCO.2005.00.612","volume":"23","author":"U Banerji","year":"2005","unstructured":"Banerji U, O\u2019Donnell A, Scurr M, et al. Phase I pharmacokinetic and pharmacodynamic study of 17-allylamino, 17-demethoxygeldanamycin in patients with advanced malignancies. J Clin Oncol. 2005;23:4152\u201361.","journal-title":"J Clin Oncol"},{"key":"2351_CR133","doi-asserted-by":"publisher","first-page":"5037","DOI":"10.1021\/jm020200g","volume":"45","author":"H Ohtsu","year":"2002","unstructured":"Ohtsu H, Xiao Z, Ishida J, et al. Antitumor agents. 217. Curcumin analogues as novel androgen receptor antagonists with potential as Anti-Prostate Cancer agents. J Med Chem. 2002;45:5037\u201342.","journal-title":"J Med Chem"},{"key":"2351_CR134","doi-asserted-by":"publisher","first-page":"348","DOI":"10.1038\/nm1547","volume":"13","author":"Z Yang","year":"2007","unstructured":"Yang Z, Chang YJ, Yu IC, et al. ASC-J9 ameliorates spinal and bulbar muscular atrophy phenotype via degradation of androgen receptor. Nat Med. 2007;13:348\u201353.","journal-title":"Nat Med"},{"key":"2351_CR135","doi-asserted-by":"publisher","first-page":"1979","DOI":"10.1093\/hmg\/ddw073","volume":"25","author":"LC Bott","year":"2016","unstructured":"Bott LC, Badders NM, Chen K, et al. A small-molecule Nrf1 and Nrf2 activator mitigates polyglutamine toxicity in spinal and bulbar muscular atrophy. Hum Mol Genet. 2016;25:1979\u201389.","journal-title":"Hum Mol Genet"},{"key":"2351_CR136","doi-asserted-by":"publisher","first-page":"5115","DOI":"10.1523\/JNEUROSCI.1242-07.2007","volume":"27","author":"H Adachi","year":"2007","unstructured":"Adachi H, Waza M, Tokui K, Katsuno M, Minamiyama M, Tanaka F, Doyu M, Sobue G. CHIP overexpression reduces mutant androgen receptor protein and ameliorates phenotypes of the spinal and bulbar muscular atrophy transgenic mouse model. J Neurosci. 2007;27:5115\u201326.","journal-title":"J Neurosci"},{"key":"2351_CR137","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1038\/nchembio.1140","volume":"9","author":"AM Wang","year":"2013","unstructured":"Wang AM, Miyata Y, Klinedinst S, et al. Activation of Hsp70 reduces neurotoxicity by promoting polyglutamine protein degradation. Nat Chem Biol. 2013;9:112\u20138.","journal-title":"Nat Chem Biol"},{"key":"2351_CR138","doi-asserted-by":"publisher","DOI":"10.1172\/JCI134565","author":"A Pluciennik","year":"2021","unstructured":"Pluciennik A, Liu Y, Molotsky E, et al. Deubiquitinase USP7 contributes to the pathogenicity of spinal and bulbar muscular atrophy. J Clin Invest. 2021. https:\/\/doi.org\/10.1172\/JCI134565","journal-title":"J Clin Invest"},{"key":"2351_CR139","doi-asserted-by":"publisher","first-page":"21713","DOI":"10.1074\/jbc.M114.628255","volume":"290","author":"S-T Chen","year":"2015","unstructured":"Chen S-T, Okada M, Nakato R, Izumi K, Bando M, Shirahige K. The deubiquitinating enzyme USP7 regulates androgen receptor activity by modulating its binding to chromatin. J Biol Chem. 2015;290:21713\u201323.","journal-title":"J Biol Chem"},{"key":"2351_CR140","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1006\/jmbi.1994.1113","volume":"236","author":"CW Gray","year":"1994","unstructured":"Gray CW, Slaughter CA, DeMartino GN. PA28 activator protein forms regulatory caps on proteasome stacked rings. J Mol Biol. 1994;236:7\u201315.","journal-title":"J Mol Biol"},{"key":"2351_CR141","doi-asserted-by":"crossref","unstructured":"Yersak JM, Montie HL, Chevalier-Larsen ES, Liu Y, Huang L, Rechsteiner M, Merry DE. The 11S proteasomal activator REG\u03b3 impacts polyglutamine-expanded androgen receptor aggregation and motor neuron viability through distinct mechanisms. Front Mol Neurosci. 2017;10.","DOI":"10.3389\/fnmol.2017.00159"},{"key":"2351_CR142","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1093\/hmg\/9.1.133","volume":"9","author":"S Simeoni","year":"2000","unstructured":"Simeoni S, Mancini MA, Stenoien DL, Marcelli M, Weigel NL, Zanisi M, Martini L, Poletti A. Motoneuronal cell death is not correlated with aggregate formation of androgen receptors containing an elongated polyglutamine tract. Hum Mol Genet. 2000;9:133\u201344.","journal-title":"Hum Mol Genet"},{"key":"2351_CR143","doi-asserted-by":"publisher","first-page":"880","DOI":"10.1038\/nature04723","volume":"441","author":"M Komatsu","year":"2006","unstructured":"Komatsu M, Waguri S, Chiba T, et al. Loss of autophagy in the central nervous system causes neurodegeneration in mice. Nature. 2006;441:880\u20134.","journal-title":"Nature"},{"key":"2351_CR144","doi-asserted-by":"crossref","unstructured":"Rusmini P, Crippa V, Giorgetti E, Boncoraglio A, Cristofani R, Carra S, Poletti A. Clearance of the mutant androgen receptor in motoneuronal models of spinal and bulbar muscular atrophy. Neurobiol Aging. 2013.","DOI":"10.1016\/j.neurobiolaging.2013.05.026"},{"key":"2351_CR145","doi-asserted-by":"crossref","unstructured":"Cristofani R, Crippa V, Rusmini P et al. Inhibition of retrograde transport modulates misfolded protein accumulation and clearance in motoneuron diseases. Autophagy. 2017;13:1280\u2013303.","DOI":"10.1080\/15548627.2017.1308985"},{"key":"2351_CR146","doi-asserted-by":"crossref","unstructured":"Cortes CJ, La Spada AR. TFEB dysregulation as a driver of autophagy dysfunction in neurodegenerative disease: molecular mechanisms, cellular processes, and emerging therapeutic opportunities. Neurobiol Dis. 2018;122:83\u201393.","DOI":"10.1016\/j.nbd.2018.05.012"},{"key":"2351_CR147","doi-asserted-by":"publisher","first-page":"1376","DOI":"10.1093\/hmg\/ddt527","volume":"23","author":"JP Chua","year":"2014","unstructured":"Chua JP, Reddy SL, Merry DE, Adachi H, Katsuno M, Sobue G, Robins DM, Lieberman AP. Transcriptional activation of TFEB\/ZKSCAN3 target genes underlies enhanced autophagy in spinobulbar muscular atrophy. Hum Mol Genet. 2014;23:1376\u201386.","journal-title":"Hum Mol Genet"},{"key":"2351_CR148","doi-asserted-by":"crossref","unstructured":"Rusmini P, Crippa V, Cristofani R, Rinaldi C, Cicardi ME, Galbiati M, et al. The role of the protein quality control system in SBMA. J Mol Neurosci. 2015;58:348\u201364.","DOI":"10.1007\/s12031-015-0675-6"},{"key":"2351_CR149","doi-asserted-by":"publisher","first-page":"e1002321","DOI":"10.1371\/journal.pgen.1002321","volume":"7","author":"Z Yu","year":"2011","unstructured":"Yu Z, Wang AM, Adachi H, Katsuno M, Sobue G, Yue Z, Robins DM, Lieberman AP. Macroautophagy is regulated by the UPR-mediator CHOP and accentuates the phenotype of SBMA mice. PLoS Genet. 2011;7:e1002321.","journal-title":"PLoS Genet"},{"key":"2351_CR150","doi-asserted-by":"publisher","first-page":"831","DOI":"10.1172\/JCI73214","volume":"125","author":"JP Chua","year":"2015","unstructured":"Chua JP, Reddy SL, Yu Z, et al. Disrupting sumoylation enhances transcriptional function and ameliorates polyglutamine androgen receptor\u2013mediated disease. J Clin Invest. 2015;125:831\u201345.","journal-title":"J Clin Invest"},{"key":"2351_CR151","doi-asserted-by":"crossref","unstructured":"Cicardi ME, Cristofani R, Crippa V, et al. Autophagic and proteasomal mediated removal of mutant androgen receptor in muscle models of spinal and bulbar muscular atrophy. Front Endocrinol (Lausanne). 2019;10:569.","DOI":"10.3389\/fendo.2019.00569"},{"key":"2351_CR152","doi-asserted-by":"publisher","first-page":"eabi6896","DOI":"10.1126\/sciadv.abi6896","volume":"7","author":"WF Lim","year":"2025","unstructured":"Lim WF, Forouhan M, Roberts TC, et al. Gene therapy with AR isoform 2 rescues spinal and bulbar muscular atrophy phenotype by modulating AR transcriptional activity. Sci Adv. 2025;7:eabi6896.","journal-title":"Sci Adv"},{"key":"2351_CR153","doi-asserted-by":"publisher","first-page":"603","DOI":"10.1038\/s41467-023-36186-9","volume":"14","author":"R Prakasam","year":"2023","unstructured":"Prakasam R, Bonadiman A, Andreotti R, et al. LSD1\/PRMT6-targeting gene therapy to attenuate androgen receptor toxic gain-of-function ameliorates spinobulbar muscular atrophy phenotypes in flies and mice. Nat Commun. 2023;14:603.","journal-title":"Nat Commun"},{"key":"2351_CR154","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1080\/14728222.2025.2464173","volume":"29","author":"A Sangotra","year":"2025","unstructured":"Sangotra A, Lieberman AP. Therapeutic targeting of the polyglutamine androgen receptor in spinal and bulbar muscular atrophy. Expert Opin Ther Targets. 2025;29:29\u201341.","journal-title":"Expert Opin Ther Targets"},{"key":"2351_CR155","doi-asserted-by":"publisher","first-page":"140","DOI":"10.1002\/ana.21540","volume":"65","author":"H Banno","year":"2009","unstructured":"Banno H, Katsuno M, Suzuki K, et al. Phase 2 trial of leuprorelin in patients with spinal and bulbar muscular atrophy. Ann Neurol. 2009;65:140\u201350.","journal-title":"Ann Neurol"},{"key":"2351_CR156","doi-asserted-by":"publisher","first-page":"875","DOI":"10.1016\/S1474-4422(10)70182-4","volume":"9","author":"M Katsuno","year":"2010","unstructured":"Katsuno M, Banno H, Suzuki K, et al. Efficacy and safety of leuprorelin in patients with spinal and bulbar muscular atrophy (JASMITT study): a multicentre, randomised, double-blind, placebo-controlled trial. Lancet Neurol. 2010;9:875\u201384.","journal-title":"Lancet Neurol"},{"key":"2351_CR157","doi-asserted-by":"publisher","first-page":"140","DOI":"10.1016\/S1474-4422(10)70321-5","volume":"10","author":"LE Fern\u00e1ndez-Rhodes","year":"2011","unstructured":"Fern\u00e1ndez-Rhodes LE, Kokkinis AD, White MJ, et al. Efficacy and safety of dutasteride in patients with spinal and bulbar muscular atrophy: a randomised placebo-controlled trial. Lancet Neurol. 2011;10:140\u20137.","journal-title":"Lancet Neurol"},{"key":"2351_CR158","doi-asserted-by":"crossref","unstructured":"Badders NM, Korff A, Miranda HC, et al. Selective modulation of the androgen receptor AF2 domain rescues degeneration in spinal bulbar muscular atrophy. Nat Med. 2018;24:427\u2013437.","DOI":"10.1038\/nm.4500"},{"key":"2351_CR159","doi-asserted-by":"publisher","first-page":"172534","DOI":"10.1016\/j.ejphar.2019.172534","volume":"861","author":"Y Wang","year":"2019","unstructured":"Wang Y, Su G, Huang Z, Fan J, Wang Y. Cepharanthine hydrochloride degrades polyglutamine-expanded androgen receptor proteins through an autophagy pathway in neuron cells. Eur J Pharmacol. 2019;861:172534.","journal-title":"Eur J Pharmacol"},{"key":"2351_CR160","doi-asserted-by":"crossref","unstructured":"Rusmini P, Cortese K, Crippa V, et al. Trehalose induces autophagy via lysosomal-mediated TFEB activation in models of motoneuron degeneration. Autophagy. 2019;15:631\u201365.","DOI":"10.1080\/15548627.2018.1535292"},{"key":"2351_CR161","doi-asserted-by":"publisher","first-page":"524","DOI":"10.1007\/s13311-023-01343-x","volume":"20","author":"M Galbiati","year":"2023","unstructured":"Galbiati M, Meroni M, Boido M, et al. Bicalutamide and trehalose ameliorate spinal and bulbar muscular atrophy pathology in mice. Neurotherapeutics. 2023;20:524\u201345.","journal-title":"Neurotherapeutics"},{"key":"2351_CR162","doi-asserted-by":"crossref","unstructured":"Tohnai G, Adachi H, Katsuno M, et al. Paeoniflorin eliminates a mutant AR via NF-YA-dependent proteolysis in spinal and bulbar muscular atrophy. Hum Mol Genet. 2014;23:3552\u201365.","DOI":"10.1093\/hmg\/ddu066"},{"key":"2351_CR163","doi-asserted-by":"publisher","first-page":"16801","DOI":"10.1073\/pnas.0506249102","volume":"102","author":"M Katsuno","year":"2005","unstructured":"Katsuno M, Sang C, Adachi H, Minamiyama M, Waza M, Tanaka F, Doyu M, Sobue G. Pharmacological induction of heat-shock proteins alleviates polyglutamine-mediated motor neuron disease. Proc Natl Acad Sci U S A. 2005;102:16801\u20136.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"2351_CR164","doi-asserted-by":"crossref","unstructured":"Oliveira RI, Guedes RA, Salvador JAR. Highlights in USP7 inhibitors for cancer treatment. Front Chem. 2022;10:1005727.","DOI":"10.3389\/fchem.2022.1005727"},{"key":"2351_CR165","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1196\/annals.1377.012","volume":"1086","author":"M Waza","year":"2006","unstructured":"Waza M, Adachi H, Katsuno M, Minamiyama M, Tanaka F, Sobue G. Alleviating neurodegeneration by an anticancer agent: an Hsp90 inhibitor (17-AAG). Ann N Y Acad Sci. 2006;1086:21\u201334.","journal-title":"Ann N Y Acad Sci"},{"key":"2351_CR166","doi-asserted-by":"crossref","unstructured":"Xie H, Liang JJ, Wang YL, et al. The design, synthesis and anti-tumor mechanism study of new androgen receptor degrader. Eur J Med Chem. 2020;204:112512.","DOI":"10.1016\/j.ejmech.2020.112512"},{"key":"2351_CR167","doi-asserted-by":"publisher","first-page":"114112","DOI":"10.1016\/j.biopha.2022.114112","volume":"158","author":"X Jia","year":"2023","unstructured":"Jia X, Han X. Targeting androgen receptor degradation with protacs from bench to bedside. Biomed Pharmacother. 2023;158:114112.","journal-title":"Biomed Pharmacother"},{"key":"2351_CR168","doi-asserted-by":"publisher","first-page":"904","DOI":"10.1038\/s41467-022-28520-4","volume":"13","author":"CH Ji","year":"2022","unstructured":"Ji CH, Kim HY, Lee MJ, et al. The AUTOTAC chemical biology platform for targeted protein degradation via the autophagy-lysosome system. Nat Commun. 2022;13:904.","journal-title":"Nat Commun"},{"key":"2351_CR169","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1186\/s13024-023-00630-7","volume":"18","author":"J Lee","year":"2023","unstructured":"Lee J, Sung KW, Bae E-J, et al. Targeted degradation of \u237a-synuclein aggregates in parkinson\u2019s disease using the AUTOTAC technology. Mol Neurodegener. 2023;18:41.","journal-title":"Mol Neurodegener"},{"key":"2351_CR170","doi-asserted-by":"publisher","first-page":"5641","DOI":"10.1074\/jbc.M609532200","volume":"282","author":"S Sarkar","year":"2007","unstructured":"Sarkar S, Davies JE, Huang Z, Tunnacliffe A, Rubinsztein DC. Trehalose, a novel mTOR-independent autophagy enhancer, accelerates the clearance of mutant Huntingtin and -Synuclein. J Biol Chem. 2007;282:5641\u201352.","journal-title":"J Biol Chem"},{"key":"2351_CR171","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1038\/nm985","volume":"10","author":"M Tanaka","year":"2004","unstructured":"Tanaka M, Machida Y, Niu S, Ikeda T, Jana NR, Doi H, Kurosawa M, Nekooki M, Nukina N. Trehalose alleviates polyglutamine-mediated pathology in a mouse model of huntington disease. Nat Med. 2004;10:148\u201354.","journal-title":"Nat Med"},{"key":"2351_CR172","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1016\/j.neuroscience.2024.06.036","volume":"555","author":"Z Wang","year":"2024","unstructured":"Wang Z, Wang M, Huang Y, et al. Trehalose prevents the formation of aggregates of mutant ataxin-3 and reduces soluble ataxin-3 protein levels in an SCA3 cell model. Neuroscience. 2024;555:76\u201382.","journal-title":"Neuroscience"},{"key":"2351_CR173","doi-asserted-by":"publisher","first-page":"1307","DOI":"10.1093\/hmg\/10.12.1307","volume":"10","author":"A Sittler","year":"2001","unstructured":"Sittler A, Lurz R, Lueder G, Priller J, Hayer-Hartl MK, Hartl FU, Lehrach H, Wanker EE. Geldanamycin activates a heat shock response and inhibits Huntingtin aggregation in a cell culture model of huntington\u2019s disease. Hum Mol Genet. 2001;10:1307\u201315.","journal-title":"Hum Mol Genet"},{"key":"2351_CR174","doi-asserted-by":"publisher","first-page":"433","DOI":"10.1007\/s13311-013-0255-9","volume":"11","author":"A Silva-Fernandes","year":"2014","unstructured":"Silva-Fernandes A, Duarte-Silva S, Neves-Carvalho A, Amorim M, Soares-Cunha C, Oliveira P, Thirstrup K, Teixeira-Castro A, Maciel P. Chronic treatment with 17-DMAG improves balance and coordination in A new mouse model of Machado-Joseph disease. Neurotherapeutics. 2014;11:433\u201349.","journal-title":"Neurotherapeutics"},{"key":"2351_CR175","doi-asserted-by":"publisher","first-page":"26188","DOI":"10.1074\/jbc.M710521200","volume":"283","author":"N Fujikake","year":"2008","unstructured":"Fujikake N, Nagai Y, Popiel HA, Okamoto Y, Yamaguchi M, Toda T. Heat shock transcription factor 1-activating compounds suppress polyglutamine-induced neurodegeneration through induction of multiple molecular chaperones**. J Biol Chem. 2008;283:26188\u201397.","journal-title":"J Biol Chem"},{"key":"2351_CR176","doi-asserted-by":"crossref","unstructured":"Lin YS, Cheng WL, Chang JC, Lin TT, Chao YC, Liu CS. IGF-1 as a potential therapy for spinocerebellar Ataxia type 3. Biomedicines. 2022;10:2.","DOI":"10.3390\/biomedicines10020505"},{"key":"2351_CR177","doi-asserted-by":"crossref","unstructured":"Sol\u00e9s-Tarr\u00e9s I, Cabezas-Llobet N, Lefranc B, Leprince J, Alberch J, Vaudry D, Xifr\u00f3 X. Pituitary adenylate cyclase-activating polypeptide (PACAP) protects striatal cells and improves motor function in Huntington\u2019s disease models: role of PAC1 receptor. Front Pharmacol. 2022:12-2021.","DOI":"10.3389\/fphar.2021.797541"},{"key":"2351_CR178","doi-asserted-by":"publisher","first-page":"11530","DOI":"10.1002\/anie.201706529","volume":"56","author":"S Tomoshige","year":"2017","unstructured":"Tomoshige S, Nomura S, Ohgane K, Hashimoto Y, Ishikawa M. Discovery of small molecules that induce the degradation of Huntingtin. Angew Chem Int Ed. 2017;56:11530\u20133.","journal-title":"Angew Chem Int Ed"}],"container-title":["Cell Communication and Signaling"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12964-025-02351-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12964-025-02351-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12964-025-02351-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,7]],"date-time":"2025-09-07T13:33:09Z","timestamp":1757251989000},"score":1,"resource":{"primary":{"URL":"https:\/\/biosignaling.biomedcentral.com\/articles\/10.1186\/s12964-025-02351-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7,17]]},"references-count":178,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["2351"],"URL":"https:\/\/doi.org\/10.1186\/s12964-025-02351-4","relation":{},"ISSN":["1478-811X"],"issn-type":[{"value":"1478-811X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,7,17]]},"assertion":[{"value":"12 January 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 July 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 July 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"344"}}